Skip to content

Regenxbio RGNX Income Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$6.39M-78.9%$30.34M+2.0%$29.73M+39.2%$21.36M-76.0%$89.01M+320%
$57.34M-3.8%$59.61M+6.3%$56.1M-5.7%$59.5M+12.1%$53.09M+5.4%
$21.31M-4.8%$22.38M+10.5%$20.25M+1.9%$19.88M-2.3%$20.35M+1.5%
$89.76M+2.0%$87.97M+7.1%$82.14M-2.9%$84.64M+10.1%$76.89M+5.9%
-$83.36M-44.6%-$57.64M-10.0%-$52.41M+17.2%-$63.28M-622%$12.13M+124%
-1,304%-1,114pp-190%-13.7pp-176.3%+120pp-296.3%-310pp13.6%+256pp
$8.71M-29.1%$12.28M-6.8%$13.17M+19.8%$10.99M+28.3%$8.57M-9.0%
-$6.69M+29.7%-$9.51M+0.2%-$9.53M-25.5%-$7.59M-25.6%-$6.04M-3,421%
-$90.05M-34.1%-$67.15M-8.4%-$61.94M+12.6%-$70.87M-1,265%$6.08M+112%
-1,408.6%-1,187pp-221.3%-13.0pp-208.3%+123pp-331.8%-339pp6.8%+248pp
-$1.72-32.3%-$1.30-8.3%-$1.20+13.0%-$1.38-1,250%$0.12+112%
-$79.51M-47.9%-$53.77M-10.8%-$48.53M+18.3%-$59.37M-469%$16.08M+134%
-1,243.6%-1,066pp-177.2%-14.0pp-163.2%+115pp-278%-296pp18.1%+241pp
-$83.36M-44.6%-$57.64M-10.0%-$52.41M+17.2%-$63.28M-622%$12.13M+124%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Regenxbio's revenue?
Regenxbio (RGNX) generated $87.8M in revenue over the trailing twelve months, down 44.0% year over year.
Is Regenxbio profitable?
Regenxbio is not currently profitable: it reported a net loss of $290.0M over the trailing twelve months, a -330.2% net margin.
What are Regenxbio's profit margins?
Gross margin is 59.7% and operating margin is -292.3%, with a -330.2% net margin.
What is Regenxbio's earnings per share?
Regenxbio's diluted EPS over the trailing twelve months is $-5.60.
Where does Regenxbio's income statement data come from?
Every line is extracted from Regenxbio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.